BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 11802479)

  • 1. [Treatment of sino-nasal polyposis by Candida albicans immunotherapy: apropos of 4 cases].
    Bénoliel P
    Allerg Immunol (Paris); 2001 Dec; 33(10):388-94. PubMed ID: 11802479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
    Silny W; Czarnecka-Operacz M
    Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
    Tahamiler R; Saritzali G; Canakcioglu S
    Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polyposis of the nasal sinuses. Epidemiology and clinical aspects of 350 cases. Treatment and results with a follow-up over 5 years on 93 cases].
    Braun JJ; Haas F; Conraux C
    Ann Otolaryngol Chir Cervicofac; 1992; 109(4):189-99. PubMed ID: 1485748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
    Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal polyposis: a study of its association with airborne allergen hypersensitivity.
    Asero R; Bottazzi G
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):283-5. PubMed ID: 11289325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research on the etiology of nasal polyps].
    Long R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1989; 24(1):34-6, 63. PubMed ID: 2641877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The viral and allergic origin of nasal polyposis].
    Klima A; Bürkle H; May A; Braun W
    Laryngorhinootologie; 1993 Mar; 72(3):131-5. PubMed ID: 8471096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized immunoglobulin E expression in allergic rhinitis and nasal polyposis.
    Wise SK; Ahn CN; Schlosser RJ
    Curr Opin Otolaryngol Head Neck Surg; 2009 Jun; 17(3):216-22. PubMed ID: 19417663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Candida albicans allergens reactive with specific IgE in asthma and atopic eczema patients.
    Khosravi AR; Bandghorai AN; Moazzeni M; Shokri H; Mansouri P; Mahmoudi M
    Mycoses; 2009 Jul; 52(4):326-33. PubMed ID: 18705661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years study.
    Giovannini M; Braccioni F; Sella G; Contoli M; Perri G; Frati F; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):69-71. PubMed ID: 15859367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histologic and immunologic study of recurring endonasal polyposis in relation to desensitization therapy].
    Alonso A; Prestisimone RE; Trotta M; Vaela MR
    Allergol Immunopathol (Madr); 1976; 4(2):121-30. PubMed ID: 779435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual specific immunotherapy reduces PBMC proliferations.
    Fenoglio D; Puppo F; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Marseglia G; Ciprandi G
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):147-51. PubMed ID: 15916016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of specific immunotherapy to mosquito bites.
    Ariano R; Panzani RC
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):131-8. PubMed ID: 15180354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of new IgE specificities to hymenoptera allergens during venom-specific immunotherapy.
    Tavares B; Rordigues F; Pereira C; Loureiro G; Chieira C
    Eur Ann Allergy Clin Immunol; 2005 May; 37(5):171-6. PubMed ID: 15984315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
    Alonso R; Enrique E; Pineda F; Basagaña M; San Miguel-Moncín MM; Bartra J; Palacios R; Cisteró-Bahíma A
    Int Arch Allergy Immunol; 2007; 143(3):185-9. PubMed ID: 17284927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy is effective in the treatment of allergic rhinitis. Retrospective study of 67 cases].
    Bleda C; Soler R; Romaguera A; Mas S; Juan JM
    Acta Otorrinolaringol Esp; 1998; 49(5):369-72. PubMed ID: 9717325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE modification of the specific antidermatophagoides during the first year of specific immunotherapy (SIT).
    Vanacore R; Ferrara MP; Berni R; Luchetti A; Gianfaldoni ML; Sbrana S; Ambrogi F
    Allerg Immunol (Paris); 1992 Dec; 24(10):387-9. PubMed ID: 1288544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.